Search by Drug Name or NDC

    NDC 63824-0713-16 Cepacol 15; 3.6 mg/1; mg/1 Details

    Cepacol 15; 3.6 mg/1; mg/1

    Cepacol is a ORAL LOZENGE in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is BENZOCAINE; MENTHOL, UNSPECIFIED FORM.

    Product Information

    NDC 63824-0713
    Product ID 63824-713_065149c7-3edf-b6ee-e063-6394a90a93a7
    Associated GPIs 88359902154795
    GCN Sequence Number 067735
    GCN Sequence Number Description benzocaine/menthol LOZENGE 15MG-3.6MG MUCOUS MEM
    HIC3 H0A
    HIC3 Description LOCAL ANESTHETICS
    GCN 30354
    HICL Sequence Number 001675
    HICL Sequence Number Description BENZOCAINE/MENTHOL
    Brand/Generic Brand
    Proprietary Name Cepacol
    Proprietary Name Suffix Extra Strength Sore Throat cherry
    Non-Proprietary Name Benzocaine and Menthol
    Product Type HUMAN OTC DRUG
    Dosage Form LOZENGE
    Route ORAL
    Active Ingredient Strength 15; 3.6
    Active Ingredient Units mg/1; mg/1
    Substance Name BENZOCAINE; MENTHOL, UNSPECIFIED FORM
    Labeler Name RB Health (US) LLC
    Pharmaceutical Class Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part356
    Listing Certified Through 2024-12-31

    Package

    NDC 63824-0713-16 (63824071316)

    NDC Package Code 63824-713-16
    Billing NDC 63824071316
    Package 2 BLISTER PACK in 1 CARTON (63824-713-16) / 8 LOZENGE in 1 BLISTER PACK
    Marketing Start Date 2013-07-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.14839
    Pricing Unit EA
    Effective Date 2021-11-17
    NDC Description CEPACOL SORE THROAT LOZENGE
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4, 6
    Classification for Rate Setting B
    As of Date 2022-06-29
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis